If the monthly results were better than the results for PRN (the de facto standard in actual practice), Roche and NVS would presumably have finished “analyzing” the comparison data by now.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.